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Abstract 
159 
Consistent with the trend hl問 centyears， !ntellectualproperty law cases figured 
prominent1y on the October 2013 docket of the U，S閉 SupremeCourt. Of the ten 
hltellectual pr'巧Jertylaw cases decided by吐leU.S. Supreme Court訟せleOctober 2013 
te口丸抱relatedto patent law.地 'dtronic[nc. 1. Mirowski F~酬ily Venture， LLC was the first of 
the six patent cases heard and decided by the Court during the term. The Court 
delivered its opinion on January 22， 2014. The issue in the case related to the burden of 
proof in a dec1aratory judgment suit fi!ed against a patentee by a patent licensee 
see油19to forestall a potent詰1patent infringement ac目。孔TheDistrict Couはheldthat 
the patentee bore the burden of proving infringement. On !lppeal， the United Stat開
Court of Appeals for the Federal Circuit reversed the judgment of the District Court 
The Federal Circuit Court ruled that a patentee bears the burden of proof in most 
hlfrir沼田n朗 tcases; but when the patent配給adefend出世inan action for a declaratory 
judgment and is prec1uded from asserting an infringement counterclaJm， the party 
seek!ng the dec1a悶 toryiudgment bears the burden of proof. In a unan!mous op!n!on， 
the U.S. Supreme Court reversed the judgment of the Federal Circuit Court. The 
Supreme Court held that the burden of proof remahls with the patentee. This paper 
presents出1叩 alys臨 ofthe Supreme Court' S ophlion出ldi胎hl1plications.
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L htrodJction圃
Consistent with the trend in recent years. intellectual property law cases figured 
prominent1y on the October 2013 docket of the U.S. Supreme Court. Of the ten 
ir時ellectualproperty law cases decided by吐leU.S. Supreme Court inせ1eOctober 2013 
拙加.six related to pat開 tlaw. Following is a brief descrip世叩of世1eSIXCases.
Medtronic lnc. v. M.開閉kiFamilyf知加re，UC ' was the first of the six patent cases 
heard and decided by the Court during the term. The Court delivered its opinion on 
J出 uary22， 2014. The 抱suein the case related 10 the burden of proof加 adec1aratory 
iud富田entsuit fi!ed against a patentee by a patent licensee seeking to forestall a 
potential patent infringement action. The Supreme Court held that the burden of 
proving infringement remalns with the patentee even if the patentee is forestalled from 
as:問 rtingan infring田 l田 tcounterc1airn by virtue of世1efactせ副社lelicensee continues 
to pay the roya1ty虹加盟lts，a1beit under proほst
The Court dellvered its op凶 onin Octane Fi師ess，LLC v.ICON Ilealth & Fitr.臨時f，Inc.2
on Aprll 29， 20 14.The case concerned the appropriate stsndard for awarding attorneys' 
fees under 35 U.S.C.量2畠5.The Court held世latthe exceptionality of a case was to be 
judged on也ebasis of血efactual and legal substsnce of a party' s case or the absence 
of good faith evidenced by the manner in which it was litigated. The Court also 
replaced the prevailing“c1ear and convincing evidence" standard of proof by a 
“'preponder組問ofthe evidence" stsnd配4
Also decided on April 2宮， 2014 was Ilighmark双Allca開 HealthMallage開elt砂s担問
The case concerned the stsndard of review to be used on appea1 from a disなictcourt' s 
finding that a case was exceptional under 35 U.S.C豊285.The Court held吐mta district 
court' s琵ndingwas to be judged by the more deferentia1 "abuse of disca註on"s'国nd町d
ra出er世国土theFederal Circuit Court' s prevailing "de novo" s出nd配4
In Nautili品 lnc双 BiosigJi削 lru間関紙 1Ilc.'，decided on June 2， 2014， the Supreme 
Court considered the nature of the definiteness reQuirement under 35 U.S.C.書112(b).
The Court held出atit was not sufficient仕mtthe c1aim be capable of being construed 
剖ldthat it be fr問。fambiguity incapable of resolution. In the Court' s holding， the 
1 Med加 nic，Inc. v. Mirowski Fa醐i砂降n邸時'， LLC，134 S.Ct. 843 
2 Octane Fitn師 S，LLC v.ICON H卸lth& Fitn酎's，lnc.，134 S.Ct1749 (2014). 
3 Highmark v.AlIcare Health Management ~初le既 134S.Ct1744 (2014). 
4N出ti/;田'，110."Bl四igl1間合唱活用en/s，ll1c.，572 U.回忌 (2014). Available at www.supremecourt 
gov/opinions!13pdf!13-369 lidf.pdf. 
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definiteness provision rcquircd that thc patent claim read along with the specification 
肌 dprosecution record should “1nform those skilled 1n the art about the scope of the 
invention with reasonable certainty吋
The Court also issued its opinion泊 LimelightNeworks， Inc もとAka醐aiTechnologies， 
IlIc." on June 2， 2014. The case concerned加ducedinfringement under 35 U.S.C. M 271. 
The Question at issue was whether a defendant could be held liable for induced 
infringement when several parties had collectively performed different steps of a 
methodp昨日lt.The Court held 1士国tdirect infringem田1cOlud only occur if alめes1εps 
of a claimed method were performed by a single party. When different steps were 
performed by different parties， there could be no direct infringement. And in the 
absen問。f也f配 tinfringement，世田recould be no induced infringement 
The most widely publicized patent case of the term was Alice Corp. v.CLS Bank 
11It'I，' becau尉 ofits pos.~ible cons問問nc朗 forsoftware patents. The Court issued its 
opinion on June 19， 2014. The ca5e involved the patentability of clalms in respect of a 
computer4mplemented finar】cialsettlement proc出 S.The Court held廿mt如 theabsence 
of出 ele田entof inv.日制on，出1abstract idea is not patentable merely on the basis也atit 
is impl，間関tedby the gen田.cuse of a ∞mputer. 
The U .S. Supreme Court' s opinions in each of th開 ecases will have significant 
effect on patent law and prac位。ein the United States. This essay presen匂 ananalysis 
of the Court' s opinion and its implications in the first of the patent cases mentioned 
abovι 世田上is，Med帥 niclnc. 1. Mirowski F，醐 ilyT初制問uc.
This essay has been structured as follows: After the present introduction， part I! 
sets out the relevant provisions of law relevant to the topic of declaratory iudgmen脂 ln
patent law cases; part rn presents a brief mention of a few significan士casesdecided by 
the United States Supreme Court and the United States Court of Appeals for the 
Fede凶 Circ叫tup 10 2007 specifically relating to declaratory ju匂mentsin patent law 
cases; oa此 IVpr出 entsan explanation of世leUnited States Supremc Court judgments 
1n出eMedl師1IIC碍se，and 1ts pr配 U出or，Me訪問踊une，Inc. v. G師entech，Inc.' and part V is 
a brief conclusion. 
5 Id.， atintemal page 11. 
'u間elightNe相IOrks，Inc.悦AkamaiTech即 logi，叫 [nc.，572 U.S. _(2014). Avallable at www， 
suprem目。u比宮:ov/op泊ions/13pdf/12-786664.pdf 
7 Alice Corp. v. CLS Banklnt'l， 573 U.S.一一(2014).Available at:www.supremecourtgov/ 
opinio:出113pdf/13-2987lh8.pdf 
， Medimmune， 1官双G抑制舵h，lnc.， 549 Uふ 118(2007). 
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江 Som告。，ftt鳴 R昏levantProv除ionsof Law Relevant t由Declaratory
Judgm睦ntn Pat号ntLitigation: 
At the ou国et，it will be useful to mention some of the relevant provisions of law 
involved The Declaratory Judg盟国1tsAct was enacted in 1宮34.It is embodied in 28 
U.S.Code ~ 2201 (a).' The federal (Juestion iurisdiction of the federa1 courts in the 
Uni臨dSta佐盟isembodied in 28 U.S. Code豊1331閉10Jurisdk世onis vested也世田federa1
courts in al patent一四latedcases. This provision is田nbodiedin 28 U掴S.Code 1338 (a)." 
Tit1e 35 of the United States Code embodies patent law in the United States." The 
Ilrovision for patent infringe田entis田tout in 35 U.S. C明白書271."
， The relevant Ilart of世leSection r朗必;
28 U.S. Code富2201-Creation of remedy 
(a)!n a四seof actual con和oversywi廿也H脂 jurisdiction.exccllt with 
r開問ctto Federal泊x出 0也紅白anactions brought under田ction7428 
of the !nternal Revenue Code of 1宮86，a Ilroceed!ng u且d町田C包on505 
or 1146 of title l1， or in any civil action involviug an an世dumllingor 
countervailin留dutyIlroceeding regard!ng a class or kind of merchandise 
of a fr酷 trade訂朗country加 definedin s配世on516A(f)(10) of the 
Tari苛Actof 1930)， as determined by世田adr凶nisterir沼 authority，百lY
∞urt of吐leUnited States. upon由efiling of an appropriate 1l1ead!ng， 
may declareせlCrighta and 0出erIcgal relatlons of any interested 関投y
seeking such declaration. whether or not further relief is or could be 
阻沼htAny such declaration shall have仕草force叩 deffect of a final 
judgment or decree and shall be reviewable酪 such.
10 The Section reads: 
28 U.S. Code事1331-F，蹴1e凶(JU朗 tion
The dislrict courts shall have original jurisdiction of alI civi1 actions 
arisiug under世間Constitution， Ia明暗ortrea旺esof the United Stat，五
11 The relevant part of吐leSection read思
28 U.S. Code ~ 1338 (a) 
The dis柱ict∞ur包shallhave original j世話dictionof田 ycivil ac世on
町isingunder any Act of Congress rela世ngto pat目指， Illant variety 
prot<対ion，CODY討副知，and trademarks. No Statε∞urt shall have 
j山知dictionover叩 yclaim for relief田isiugunder剖lyAct of Co時間関
relating to patents， Illant variety prot配目。凡orcOllyrighta.... 
12 The law has been enacted IlU脂uantto Section 8. Clause 8 of世田u.s.co盟国tution
whereby Cougrεssisv田tedwith the power“'[tJo Ilromote血eprogress of science 
田ldu田fular包 bysecuring for limited世田esto aU'由。問問dinventors the exclusive 
right加 theirr出:pectivewritings and discoveri出子
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Following are a few relevant major rulings of廿leUnited Stat田 SupremeCourt叩 d
the Unlted States Court of Appeals for the Federal Circuit relating to declaratory 
iudgments in patent litigation suits. prior to the Supre臨 eCourt' s iudgment in 
Medi加 'nic.
In Altvater玖 Freeman." the U.S. Supreme Court upheld the maintainability of a 
counterc1aim by a patent licensee seeking a dec1aration出atthe patent at issue was 
invalid even也oughthe licensee continued to make royaity payments pursuant to a 
court injunc討。孔TheCourt' S opinion stated: 
Unl日弼世leinjunction decree were modified. [f，∞tnote oml岱edJ
世leoniy 0血ercourse was to defy it，釦dto risk not oniy actual 
but treble damages in infringement suits.. It was出efunction 
of the Dec1ar底知'ryJu匂mentAct加 affordre1ief against sucb 
peril and insecurity.... And certainly the reuuiremen出 ofcase or 
controversy are met where payment of a c1aim is dem田 ded田
of ri罫:ht阻 dwherepaym回 t18 made， but where吐leinvol出血ry
or coercive nature of the exaction pr，出ervesせleright to r，叫.over
世間sumspaid or to challenge世理legalityof也ec1aim.!5 
In C.R.Bard， lnc. もと Schwartz，" the U.S.Court of Appeal8 for the Federai Circuit held 
出品adec1aratory judgment配 tioncould be brought by a patent lic剖1Se even出ough
the patent license had not been ter臨inated，where the licensee had a "rea80nable 
a:oprehension of an infringement suit"17 
13 Sub-s配はon(a)of 35 U.S.C喜271r，拍必:
35 U.s.C.霊271-Infringement of patent 
(a) Exapt開。世班wiseprovided in世話8tit1e， whoever帆世l0utauthority mak見
U配s，offers to配 llor田elsany patented !nventlon， wi社世n吐lC
Unlted S凶器orImporis in出血eUni怯dS泊も出叩ypa土問士edinvention 
during the term of the patentせをerefor.組fring出血epatent 
14 Altvater v. Fr世間an，319 U.S. 359 (J宮43).
151d.， at365. 
l' C.R.Bard，lnc.税 Schw，酎営z，716 F.2d 874 (FedCir.1983) 
17 ld.， at 880 
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The “reasonab1e apprehension of an infringement suit" test set out in Bard was 
su凶eQuentlyfollowed in a series of decisions by出eFederal Circuit Court." 
In Cardinol ζ;0. V. Morton lnternational， lnc.， "世田U.S.Supreme Court ruled that a 
finding of patent non-infring出τlentd日盟notby itse!f constitute a reason for vac低inga 
dedaratory judgment of patent invalidity. 
in Gen-Probe lncorporated 1. ~世'sis， lnc.，" the Federal Circ凶tCourt dis百nguishedand 
refined its ruling in Bard. In Bard， a1though the license had not been terminated， the 
Iicensee had committed a material breach of the Iicense agreement and the 
patent-holder had fi!ed a suit for re∞，very of the cont悶ctedroyalty. ln Gen-Probe， the 
Iicensee had not committed any breach of the Iicense agreement when it fi!ed its 
declaratory judgment suit， and r聞 lainedin耳目対抗叩必ngwhile pr，日記cu儲19itslm開 uit.
ln these circurnstsnces， the Federal Circuit Court held that there was no reasonable 
apprehension of suit， and therefore no actualωntroversy between the parti蹴 Thereby，
the Court held that an action under the Declaratory Judgment Act could not be 
maintained 
IV. n鳴 Juc量産mentsof甘鳴 Unit師 St晶tesSLPr宙n嘗Courtin Medimmune and 
Medtronic: 
The most significant cases relating to declaratory judgments in the context of 
patent litigation areめeMedimmune and Medtronic cases decided by the UniほdStates 
Supreme Court in 2007剖ld2014 respectively. Following is a brlef expl印刷onof the 
Supreme Court' s opinions加世田twocases: 
A. Medimmune， 1nc. v. G抑制techJJnc.21: 
The Supreme Court here 田町ideredthe soope of the Case or Controverち:yClause of 
A吋icleII of the U.S. Constitution in the context of declaratory judgments in patent 
H世ga世0孔m
l' See， e.g. The Goodyear万即&Ruhber Company税 Releasomers，Incリ 824F.2d 953 
(FedCir.1987).四dA即 wheadlnd:出:trial助制lnc.税 Ecolochem，Inc目， 846 F.2d 731 
(FedCir.1988) 
19 Cardinal Chemical Co.， v.Morton 1nternational， 1nc. 508 U.S.83 (1993). 
田 G醐-1'1幼eIncorporated 1.砂'sis，Inc. 35世F.3d1376 (FedCir.2004) 
21 Med，棚醐U問 l"c.v. G.醐enlech，lnc.，549 U.S. 118 (2007). 
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Medimmune entered into a paten土licenseagreement wi也 Genentechregardingせle
manufacture of specified medication drug. Genentech was the patentee and 
Medirnrnune was the licensee. During the subsistence of the agreernent， Genentech 
clairned出atMedin1rnune' s drug Synagis was covered by a patent held by Genentech 
and therefore called upon Medirnrnune to pay royalty under the patent license 
agreement. Medimrnune disputed the validity and enforceability of Genente氾h's patent， 
and further contended吐latin any event Synagis did not infringe the c1airned patent 
Neverthel田s，fearing the possible onerous consequences of refusing to pay royalty 
Medirnrnune made the dernanded royalty payrnents under protest and filed a 
declaratory-judgment suit. The Dis制ctCourt dismissed Medimmune' s smt on吐lebasis 
of a decision" of the U.S. Court of Appeals for the Federal Circuit. The Federal Circuit 
precedent had held that a patent Iicensee who cornplied with the terrns of世田license
agreernent could not challenge the patent' s validity， enforceability， or scope as the act 
of comp1iance removed any “reasonable apprehension".u， of an infringement action， 
which in turn defeated the case or controversy reQuirement of Article II of the U.S 
Constitution. Relying on the sarne precedent， the Federal Circuit affirrned the District 
Court. By a rnajority opinion，甘1eSupreme Court陀 versed吐lejudgment of the Federa1 
Circmt Court of Appeals 
τ'he Court fi陪taddre田 eda preliminary lJQint regarding出edispute Genenたchhad
contended that Medimmune merely diSjluted the validity of Genentech' patent and not 
the fact 出atits product infringε:d the pat印 t朗 dthat the license requはredMedimmune 
to pay the royalty i町田，pectiveof the patent' s validi士y.The Court rejected G四 .entech's 
contentions as both points had been c1early dlsputed in Medlmmune' s pleadings 
担 τ'heC田eor Con甘oversyClaus把 isemb吋iedin Article 11， Section 2， Clause 1 of世田
U.S. Cons抗tutio江 ltr田 ds酪 fo11oV¥唱
The judicia1 power sha11 extend to a1 cases，血lawand equity， ari剖ng
under出sConstituは0九仕lelaws of世間UnitedSts出s，出ld廿田.ti田
made， or which sha11 be made， under也日rauthority; -to a11 c出自
affec世且富国的措sado田，。出erpublic ministe出訂正dconsul忠一toal 
cases of admira1ty朋 dmaritime jurisdiction; 加 con甘Dver芯iesto 
which the United Statβs shall be a party; -to controverちiesbetween 
two or more st成田;--between a state出1dci百zensof田10出erstate; 
between citizens of different st酷es;-between citizens of吐lesame 
s匂.tec1a1ming lands under gran脂 ofdlfferent stat四，and between a 
state，or也ecitizens thereof， and foreign states， citizens or subjec臨
時InGen-Probe Inc双砂'sis，Inc.， 359 F.3d 1376 (2004). 
叫 ld.，at 1381. 
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Genentech also c四1民nded仕mtMedimmune had not disputed the contract組世lelower 
courts and thereby it had waived its right七odo 80. However，出iswas con廿aryto the 
record as the argument had in fact been raised in Medimmune' s brief before the 
Federal Circuit Court 
The Court then addressed the Ques討onof ju出品iction.The Court noted仕latthere 
was no gainsaying that世田rewas a genuinely disputed issue betw配 nせleparties. The 
essential question was whe吐lerMedimmune' s continuing payment of royalty cause活
仕leArtic1e lI-mandated case or conuoversy between世出partiesto cea.~e. The Court 
noted that several of its own precedents had held that where an individual is 
confronted with the threat of governmental action， the fact that the individual takes 
steps to obviate the risk of prosecution， does not defeat the right to maintain a 
declaratory judgment action. Lower court had recognized the maintainability of 
declaratory judgment suiL~ even where the threatened action was by a priva総 party
The Court then cited i脂 owτ1precedent血 Altvaterv. Fi開 eman.l栢 Thiswas a patent case 
involving private parties， where the Court had recognized the maintainability of a 
dec1aratory judgment suit in which plaintiff continued to make royalty payments in 
compliance with a court injunction while seeking a declaration that the patent in 
qu出世.onw出 invalidIn the Gen.Probe casιthe Federal Circuit Court had distinguished 
Altvater on世leground that世田 royaltypayments had been made pursuant to a court 
injunction. The Supreme Court， however， rejected the distinc世onbecause Al.釦aterhad 
stated t出atif the plaintiff had refused to comply wi出 theInj山lction，吐leconse屯uence
would have been infringement suits for damages. No mention had been made of any 
rlsk of govemmental action. The Supreme Court組問d日;linedto accept the relevance 
of a judgment in剖1earlier case which had been decided before the enactment of世le
Declaratory Judgment Act and the upholding of its validity. 
Genentech argued that the license agreement effectively protected Medimmune 
from an infringement action so long as it paid吐lestipuiated royaltiむs.If Medimmune 
were permitted to maintain the Declaratory Judgment action， itwould transform the 
terms of the agreement. Medimmune would then continue to enjoy its contracted 
protecti田1while at the sarne time seeking to nullify Genentech' s right to institute an 
infringement actlon. The Court rejected this argume 
25 Altvater v. Fr世間an，319 U.S. 359 (1宮43).
BULLETlN OF KYU証ruWOMEN'S UNIVERSITY VoL51 No.2 167 
subsisting patents did not defeat its right to seek a declaration tbat世lCoatents were 
invalid Genent母chinvoked a common-law rule refusing to permit a oontracting party 
to (juestion tbe contract' s validity even酪 itenjoyed仕理由n士ract's benefits. The Court 
reJec匝d也is訂邸J1Ilentas Medimmune was not qu田tioning仕lecon土問cfs validity but 
wasmerelys間 kingto錨世rrtaini胎 co汀'ectinterpreta世01.
F恒温Iy，Genentech urged tbat tbe relief田 ughtfor under世田DeclaratoryJudgment 
Act was discretionary， and that the Supreme Court should refuse to exercise this 
discretion in favor of Medimmune. The Court opined tbatせleDistrict Court was the 
appropriate forum for adiudicating出S(jU酪世.on.
The Supreme Court held that M日iimmunecould m討ntaini抱 declaratoryjudgment 
suit even as it complied witb tbe terms of i陪 licenseagreement wi世1Genentech. The 
Court reversed and remanded廿lejudgment of世leFederal Circuit Court of Appeals. 
Following tbe SupremεCourt' s judgment in Medi隅棚田e，tbe Federal Circuit Court 
held in SanDisk Corp玖 STMicroe/ect.同 nics鵠 tbatjurisdiction under the Declaratory 
Judgmen胎 Actcould be validly invoked when叩a11egationof patent infringement had 
been made in世間叩urseof negotiation. 
B.M滅的財'c.h前祝Miro附 kiF，醐 ily~勧血児'， LLC 釘
The plaintiff Medtronic was the Iicensee in respect of patents rela世ngto certain 
healせl-felateddevices. Defendan士Mirowskiwas the 0明 nerofせlepatents. The patent 
agreement had a clause stating tbat if Mirowski beliほvedtbat a Medtronic product 
infring陪da Mirowski patent， and natified Medtronic of such infringement， Medtronic 
could pay甘1enecessary royalty. If， ho明 ever，Medtronic dlsPuted Mirawski' s a出 ertlon，
then Medtranic couid pay tb.e royalty provisionally and at由esame世田.ed国Ilengethe 
26 SanDisk C.田p."STM加。e/，町b句nics，480 F.3d 1372 (F，日以;ir.2007).The 0凶lionstat四:
We hold oniy吐mtwhere a paten舵eass位協rightsunder a patent 
b描吋 on出抗a1niden姐fiedong，話ngor pl郡田edactivity of anatber 
P町匂"田ldwhere仕国土p訂 ty∞n睦ndsせlatit h出世田ri宮htto engage 
in世1eaccused act制 ty制出outli田 nse，an Ar甘cle11田seor 
∞ntroversy will arise andせlep紅tyne既Inot ri法 asuit for 
infringem田ltby engaging加 tbeidentified ac世vitybefo間関eking
a deciar逸品onof吐1clegal rights， 
Twoother話gnifi叩ntd配 isions開la也19tad除clほratoryjudgments issued by tbe Federal 
C註cuitCourt p田 t-Med抑制開ewerein烏糊Ph師明白 E芯4v.M削唱rtisPharm. Corp. 482 
F.3d 1330 (Fed Cir. 2∞7)， and Sony Electroni回'，Inc，私G叫 rdianMedia Technologi出'，Ltd，リ
497 F.3d 1271 (F，出土Cir.2007).
幻 Medtronic，Inc双M，同wskiF，醐 ilyfen山間'，LLC，st伊'7Qnote 1 
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validity of Mirowski' s asser世onby a declaratory judgment suil If Medtronic failed to 
do either， Mirowski could terminate the Iicense and sue for infringement. A later 
modification of the agreement provided that the payment of royalty pending the 
outcome of出edec1aratory judgm四土suitwouid be pl配 edin組曲crowa，∞ount.
Sut描eQuent!y，a dispute ar，時ealong tI1e lines envisaged by tI1e patent agreement. 
Mirowski notified Medtronic that some of its products violated c1aims in Mirowski' s 
paten士S.Medtronic denied this and sought to test the validity of Mirowski' s assertion 
by朗朗nsof a Declaratory Judgment suit. In tI1e suit Medtronic urged出attI1e products 
in Question did not infringe any of Mirowski' s patents， and that tI1e patents were 
invalid. Jn吐lemeantimιit pald the dema且dedroyalty in知即時crowac∞iUnt
The District Court placed the burden of proving infringement upon the 
defendant/patentee， that is， Mirowski. Upon a finding that Mirowski had not proven 
infringement， tI1e Court held for Medtronic. Upon appea!， the U.S. Court of Appeals for 
the Federal Circuit held that the burden of proving non-infringement lay明riththe 
pl出掛ffβi町田ee，白紙is，Medtronic. Upon Medtronic' s petition， the U.S. Supreme Court 
granted cer世.orarion世田郡部tionof tI1e burden of pr，∞f. 
ln an opinion autl10red by Justice Breyer， the Supreme Court first dealt with a 
jurisdictional question raised by an出口icus.lt was con胞nded世1atthεFederal Circuit 
did not have subject-matter jurisdiction in this case because if Medtronic would 
con世且ueto田国lUfac!ure也eproducts in QU田tionw世10utpaying royalty田ldwitl10ut 
a deciaratory judgment in i18 favor， Mirowski would have to file a suit for breach of 
contract， and not for patent infringement. The Court noted the acknowledged 
jurisdict!on of the federal d!strict courts in matters relat!ng to patent law and the 
Federal Circuit Court' s exclusive appeliate jurisdiction over such matters. The Court 
a1so accepted the contention that the Dec1aratory Judgment Act did not extend tI1e 
jurisdiction of tI1e federal courts，邸時tI1attI1e crucial question to be exan1ined was the 
nature of tI1e suit也.atwas sought to be precluded by the plain世fin the dec1aratory 
judgment suit However， the Court did not ac間以出econ胞ntion世mttI1e na士ureof such 
suit in the present case would be for a breach of contract， but rather opined that it 
wouid be a patent infringement ac世間.On出.atbasis， tI1e Court upheld tI1e jurisdiction 
of tI1e Fede油 1CirCl叫tCourt. 
The Court tI1en turned to世田auestionat issue regardingせleburden of pro悶f.τ'he
Court' s based its op凶 onon a two-<ltep analysis. F出 t，rely註19upon se枕ledpreceden胎，
the Court noted: (i) the patentee usual1y bears the burden of proof in a patent 
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infr1ngement action; (ti) the Decla悶 toryJudgment Act 1s only procedural and does not 
alter a substantive element; and (ii) the burden of proof is a substantive element On 
that bas1s， the Court held that the in the present action， the burden of proof should 
remain wi由也epatentee/defendanl，世lat18， Mirowski 
The Court then considered the practical implications of holding otherwise. If 
plaintiffjMedtronic was denied the declaratory judgment in its favor，出ldif it 
persisted in manufacturing the allegedly infringing product， the defendant/Medtronic 
would have to file a patent infringement action. ln such a suit， Medtronic would 
certainly be虹めeburden of proof. It is conceivable出atMirowski could lose白紙suit
because it failed to carry its burden of proof. ln such an event， the result would be 
confusion among 81 ∞ncemed in respect of the parties' rights regardlng也epatented 
products." Thus，性百declaτatoryjudgment in such a situation would con位meto leave 
op抽出CQu朗目onof the exact leg81 rights of the p町ties.Furthe口即時ina c弘明間.ch酪
the present one， the Iicensee denying infringement would be hard put to carry the 
burden since it cannot know the exact grounds on which the patentee is c1aiming 
infringement Finally， citing its earlier judgment in Med，問 mune，Inc. v. Genentech， Inc.，29 
世田Courtstated白紙shiftingthe burden would defeat the PU1官。seof tbe Declaratory 
Judgment Act as it would prεsent the plaintiff/licensee with the difficult choice of 
either giving up its rights or incurring世田riskof a suit. 
The Supreme Court disagreed with the correctness of the grounds on which the 
Federal Circuit Court had based its judg臨 ent.ln the Court's opinion， the Federal 
Circult' s reliance on Schaffer 11.険副知W描 mispla田dA1仕lough仕leSupreme Court had 
noted in Schafer that世1eordinary default rule reQuired the pla!ntiff to bear the burden 
of proof. Schafer did not involve a declaratory judgment sult. Furthermore， in Schafer， 
the Court had recognized that there are exceptions to the rule. The inst忍ntcase 
pre配ntedone such exceptio孔 TheFeder81 Circuit had limited its holding to a case開 ch
asせlCpresent one where世1epatentee was forestalled from bringing an infringement 
油 TheCourt relied on Section 28(4) (1事80)of TheR出tate出掛t(Second) qf Judgments to 
support il国 stat怠mentabout吐leshif世ngof the burden of pr，∞f. 
拍 Med開mu開~.lnc. 税 G四entech， lnι， 549 U.S. 118， 137 (2007). 
拍 Schaffer税険制t，546 U.s.4告(2005)
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counterclaim bccausc of the Iicensec' s continuing adherence to the tcrms of the 
agreement The Supreme Court noted that such situations are common when a licensee 
is accused of infringement. and血.atsuch a situation had in fact arisen in the earlier 
Medim醐unecase where the Court upheld the constitutiona! validity of a declaratory 
iudgment suit Moreover. merely re柑icting甘leapplicabi1ty of a rule do時 notby i相elf
va!idate it An a国 cushad urged出atplac担冨世leburden of proof on吐lCpaten土ecwould 
invest the licensee with the leverage to push the patentee into filing a patent 
infringement suit. The Court dismi開 edthe argument because such an action could 
only be sustalned in cases of genulne dispute. The public interest was evenly weighed 
in favor of a properly working patent system on the one hand and the refusal to 
count自国且ce也eabuse of a patent right on吐leother. 
For吐leser闇邸時世leSupreme Court rev，世田dthe Fed町'a!Circult' s judgment. 
V. C日間lusio町
The United States Supreme Court decided six patent cases in its October 2013 
term. Th崎 isin line with the increasing importance of intellectua! property and the 
growing recognition of its role in the economic prosperity of nations.$t The United 
Stat田SupremeCourt reversed the judgment of the Unlted Stat，田Courtof Appeals in 
five of the six patent cases. This raises interesting issues about the exclusive 
iurisdiction of Federal Circuit Court in respect of appeals in patent cases." In a 
percept!ve law review article in the Yale Law Journal. Peter Lee has pointedly 
highlighted世間d丘ferenc田 inperaptions betw田 nthe specialist Judges of the Federal 
Circuit Court and the Justices of the United States Supreme Court. and the recent 
'bolistic" view of the Supreme Court泊 patentcas出 asagalnst the more“お口nalistic"
approach of the Federal Circuit Court. The Medim醐即時 andMedtronic cases arc 
reflective of this trend 
τbe Supreme Court' s judgment in Medtronic is clearly more beneficial for licens酎盟
vis-a-vis patent holders. Any expressed statement by a patent holder that its patent is 
being infringed by a Iicensee' s product could trigger a declaratory iudgment suit. 80 
long as the Iicensee ∞n加 uesto abide by thc terms of the license. The patentec would 
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bear世leburden of making good its stsnce. The Iicensee need not feelpressured into 
accepting the patentee' s demands， without recourse to a remedy， or risk losing its 
righ国 under世lelicense. 
As a practical matter， from the viewpoint of世間patentee，one conseQuence of血is
could be an a牧師nptto deter a dec1aratory iudgment suit by inserting a c1ause加 the
license agr配 mentwhich invests世lepaten土ee刷出世もeright to terminate the agreement 
uponms世tu虹onof such a suit Of ∞urse， the va1idity of such a clause will inevitably be 
ca11ed into (juestion and頂点1be a subject of judicial determination. lt could a1so be in 
the interest of both lic叩.seesand patentees岡田utua11yprovide for alternative mode渇
of d1apute resolu世on.
1n any event， the Medtrollic judgment reconfigures the negotiating positions of 
patent Iicensees and patent-holders and is sure to have a significant impact on the 
shaping of patent licensing agreements in the y抽出tocome. 
31 See.忽芯， America Inven土sAct， f五R.124宮， 112也Cong.Section18:“ 
Increasingly our nation has an information based economy， andせle
key to such and economy is intel出切alprQPeはysuch出 patents，
copyrights and trademarks. Studies establ泊h甘latin胞l1eιtual
pr叩 e社ydrives出se∞nomy出世letune of 5廿iliondollぽs，
accounting for half of a1日U.S.問 ports剖ld部 lployin喜nearly
18 m1Ilion workers. 
担 The U.S. Court of Appeals for the Federal Circ四twas constitu士官1in 1宮82.The stated 
rationa1e w悶
to bring about uniforτnity of decisions in ce出担criticalareas of 
the law wi出outthe need for Supreme Court reviewもOf;自由，lve
conflicts between circuits To this end the Federal Circuit was 
given exclusive jutisdiction over appeals from 01 dおおictcourts 
加山部eswruch arise under the patent Iaws...A particular need was 
駒田inthe fie1d of paten士swhere instability in世田Iaw官邸having
a de!rimental effect on an importsnt segment of our society，世le
indus位ia1and business community. 
Bennet， Marion T. The Un出'd~抑制 C部副 ofAppe油for 品eF，臨leralCj，明，;t:AHistory， 1982-1990， 
a土xi(l宮91)Washingぬn.D.C， The U.SJudicia1 Conference Committee on世田Bicentennia1
of吐1eConstitution of吐1eUnited States， 1991. 








6事例は特許法に関するものであった。 MedtronicInc. v. Mirowski Family I'初担問 LLαま
6つの特許法の訴訟で最初に審理が行われ、 2013年から2014年の期間で判決が下されたも
のである。法廷は2014年1月22自にその見解を言い渡した。その宣言的判決訴訟の立証責任
に関する問題は、潜在的な特許権侵害訴訟を出し抜とうとする、特許実施者によって、特許
権所有者に反対するものとして申告された。地区の裁判所は、特権所有者が立証責任的な侵
害を負うと考えた。上訴では、アメリカ合衆国連邦巡回区控訴裁判所は、地区裁判所の判決
を逆転した@連邦巡回区控訴裁判所は、特権実施者がほとんどの侵害事例において、立iliE責
任を負うと制定した。しかしながら、特権実施者が宣言的判決の訴訟被告であり、侵害訴訟
の反訴の主張を打ち切りにするところでは、宣言的判決を求める側が立証責任を負う。満場
一致でアメリカ合衆国最高裁は連邦巡回区控訴裁判所の判決を逆転した。法廷は立証費任が
特権実施者に留まるものとした。この論文では、最高裁判所の意見とその推断の分析を提供
している。
